These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 13997558)

  • 1. [The exactness of the practical measurement of active serum isoniazid levels by the vertical diffusion microbiological method].
    VIVIEN JN; THIBIER R; LEPEUPLE A; GROSSET J
    Rev Tuberc Pneumol (Paris); 1962; 26():978-88. PubMed ID: 13997558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison between 2 methods, chemical and microbiological, for determination of plasmatic isoniazid].
    Fantoli U; Zubiani M; Cattaneo C; Lucchesi M
    Ann Ist Carlo Forlanini; 1965; 25(1):53-65. PubMed ID: 5830579
    [No Abstract]   [Full Text] [Related]  

  • 3. [A method for the elimination of errors connected with the vertical diffusion technic used for the determination of active INH in the blood serum].
    PREGOWSKI W
    Gruzlica (1926); 1961 Mar; 29():255-7. PubMed ID: 13737819
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL VALUE OF THE DETERMINATION OF THE ACTIVE INH LEVEL BY THE VERTICAL DIFFUSION METHOD IN TUBERCULOUS PATIENTS].
    Gruzlica (1926); 1963 Oct; 31():1021-7. PubMed ID: 14092755
    [No Abstract]   [Full Text] [Related]  

  • 5. [CHEMICAL DETERMINATION OF BLOOD LEVELS OF ISONIAZID IN MAN AFTER ITS ADMINISTRATION BY VARIOUS METHODS].
    RAITERI M; CALCHINOVATI C
    G Ital Tuberc Mal Torace; 1963; 17():122-6. PubMed ID: 14054310
    [No Abstract]   [Full Text] [Related]  

  • 6. [METHOD FOR EVALUATING THE STRENGTH OF SYNTHETIC ANTIBIOTICS IN THE BLOOD SERUM DURING CHEMOTHERAPY OF TUBERCULOSIS].
    OKAMOTO K; FUJINAGA R; YAMAUCHI H
    Kekkaku; 1963 Sep; 38():413-7. PubMed ID: 14056005
    [No Abstract]   [Full Text] [Related]  

  • 7. Interference of isonicotinyl hydrazone in the microbiological analysis of rifampicin from anti-tuberculosis FDC products containing isoniazid.
    Mariappan TT; Geetha T; Pandey R; Jindal KC; Singh S
    J Pharm Biomed Anal; 2004 Nov; 36(3):643-7. PubMed ID: 15522543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TESTING FOR ACTIVE INH IN THE CEREBROSPINAL FLUID AND BLOOD OF PATIENTS WITH TUBERCULOUS MENINGOENCEPHALITIS. (PRELIMINARY COMMUNICATION)].
    STRUPCZEWSKA-JANUSZOWA H
    Gruzlica (1926); 1963 Mar; 31():219-26. PubMed ID: 14060346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complementary data on the determination of active isoniazid of the blood serum by the method of vertical diffusion. Determination in presence of PAS].
    GROSSET J; CANETTI G
    Rev Tuberc Pneumol (Paris); 1960; 24():633-47. PubMed ID: 13829677
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct injection of solid-phase extraction eluents onto silica columns for the analysis of polar compounds isoniazid and cetirizine in plasma using hydrophilic interaction chromatography with tandem mass spectrometry.
    Li AC; Junga H; Shou WZ; Bryant MS; Jiang XY; Naidong W
    Rapid Commun Mass Spectrom; 2004; 18(19):2343-50. PubMed ID: 15473002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurements of isoniazid in serum.
    SCHMIDT LH
    Am Rev Respir Dis; 1962 Oct; 86():561-3. PubMed ID: 13992023
    [No Abstract]   [Full Text] [Related]  

  • 12. [A METHOD FOR THE DETERMINATION OF THE "PREPARATION 17" IN THE BLOOD SERUM].
    DANIEL A
    Suvr Med (Sofiia); 1964; 15():40-2. PubMed ID: 14258738
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effects of prednisone and dexamethasone (associated with bacteriostatics) in the clinical course and plasma parameters in pulmonary tuberculosis patients].
    EL-DEWI T; BONSTEIN H; FAVEZ G
    Schweiz Med Wochenschr; 1962 Nov; 92():1398-403. PubMed ID: 14028692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modification of methods of biological measurement of isoniazid in blood serum; results in 53 cases].
    GROSSET J; GRUMBACH F; CANETTI G
    Ann Inst Pasteur (Paris); 1957 Jun; 92(6):752-9. PubMed ID: 13444792
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE LEVEL OF BIOLOGICALLY-ACTIVE INH IN THE PATIENT'S BLOOD].
    ZDUNCZYK PAWELEK H; BLITEK GOLC D; KOSTRZEWSKA K
    Gruzlica (1926); 1962 Jul; 30():605-14. PubMed ID: 14077880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controversies in the determination of serum albumin concentration in chronic liver diseases].
    Uchida Y; Okuzumi Y; Fujishiro M; Kawamura K; Shibasaki M; Shimetani N; Suzuki K
    Rinsho Byori; 2006 Oct; 54(10):1008-12. PubMed ID: 17133989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow injection chemiluminescence determination of isoniazid using the lucigenin-periodate system.
    Du J; Lu J
    Luminescence; 2006; 21(1):26-30. PubMed ID: 16100740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of isoniazid and ethambutol in human plasma.
    Chen X; Song B; Jiang H; Yu K; Zhong D
    Rapid Commun Mass Spectrom; 2005; 19(18):2591-6. PubMed ID: 16106359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive indirect spectrophotometric determination of isoniazid.
    Safavi A; Karimi MA; Hormozi Nezhad MR; Kamali R; Saghir N
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Mar; 60(4):765-9. PubMed ID: 15036086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.